Evidence mapPaperPMID 42388620Full record

ReviewFrontiers in oncology2026

The long road after breast cancer: survivorship issues and long-term treatment effects in young women.

Martina Pagliuca, Roberto Buonaiuto, Annarita Verrazzo, Sara Parola, Margherita Tafuro, Claudia Calderaio, Claudia Martinelli, Rossana Di Rienzo, Miriam Pirolo, Christian Zurlo and 8 more

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Martina Pagliuca *Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Roberto Buonaiuto *Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Annarita VerrazzoClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Sara ParolaDepartment of Breast and Thoracic Oncology, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy.
Margherita TafuroClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Claudia CalderaioClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Claudia MartinelliClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Rossana Di RienzoClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Miriam PiroloClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Christian ZurloClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Ornella TinelliClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Roberta ValenteClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Luisa CirilloDepartment of Breast and Thoracic Oncology, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy.
Martina AutieroDepartment of Breast and Thoracic Oncology, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy.
Maria Luisa D'Aulisio GarigliotaClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Raffaella Di MondaDepartment of Breast and Thoracic Oncology, IRCCS Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy.
Carmine De AngelisClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.
Michelino De LaurentiisClinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in early detection and treatment have significantly improved survival rates in young women with breast cancer, leading to a growing population of long-term survivors. However, survivorship in this population is characterized by a unique and complex set of challenges that extend well beyond the completion of active treatment. This review aims to provide a comprehensive overview of the long-term physical, psychological, reproductive, and social effects of breast cancer and its treatment in young survivors, highlighting the need for tailored, age-specific survivorship care. Young breast cancer survivors are particularly vulnerable to treatment-related sequelae due to the interaction between therapy-related toxicities and critical life stages, including family planning, career development, and relationship building. Common long-term physical effects include bone density loss associated with premature ovarian insufficiency, cognitive dysfunction, and persistent cancer-related fatigue. In addition, endocrine therapies and treatment-induced menopause contribute to vasomotor symptoms (VMS), sleep disturbances, weight gain, and sexual dysfunction, all of which can significantly impair quality of life. Psychological distress is highly prevalent in this population, with elevated rates of anxiety, depression, post-traumatic stress, and fear of cancer recurrence. Fertility and reproductive health concerns represent a central issue, encompassing fertility preservation, pregnancy after breast cancer, and the safety of interrupting endocrine therapy. Social challenges, including difficulties with return to work, financial toxicity, and disruptions in intimate relationships, further compound the survivorship burden. Despite increasing recognition of these issues, many remain underdiagnosed and undertreated. A multidisciplinary, patient-centered approach is essential, integrating oncologic care with primary care, reproductive endocrinology, mental health services, and supportive care interventions. Early counseling, routine screening, and proactive management of long-term effects are key components of optimal survivorship care. By synthesizing current evidence, this review underscores the importance of developing comprehensive survivorship strategies tailored to the specific needs of young breast cancer survivors, with the ultimate goal of improving long-term outcomes and enabling patients not only to survive but to thrive after breast cancer.

Indexed as

breast cancerlong - term effectpsychological issuessurvivorship careyoung survivors

Identifiers

PMID42388620
PMCPMC13318801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.